Indications 

Tricor Nanocrystallized is a cholesterol-lowering medication that belongs to the class of drugs known as fibrates. It helps lower levels of “bad” cholesterol (LDL cholesterol) and triglycerides in the blood, while also increasing levels of “good” cholesterol (HDL cholesterol). It is typically used as an adjunct to diet and other lifestyle changes when these measures alone are not sufficient in managing cholesterol levels. 

Tricor Nanocrystallized, also known as fenofibrate nanocrystallized, is a medication used to treat high cholesterol and high triglyceride levels in the blood. It belongs to a class of drugs called fibric acid derivatives. It works by affecting the production and breakdown of lipids (fats) in the body. It primarily targets triglycerides, which are a type of fat found in the blood. Tricor Nanocrystallized activates a specific receptor called peroxisome proliferator-activated receptor alpha (PPAR-alpha) in the liver and other tissues. 

Use and Dosage 

Tricor Nanocrystallized should be taken orally with a glass of water once a day, with or without food. Take Fenofibrate Nanocrystallized tablet exactly as prescribed by your doctor. Do not take more or less than the recommended dose. Some brands of Fenofibrate Nanocrystallized may be taken with or without food, while others may be more effective when taken with meals. Follow the specific instructions provided by your healthcare provider or the directions on the medicine label. Do not crush, chew, dissolve, or open the tablet. 

Take Fenofibrate Nanocrystallized tablet at the same time each day to help you remember and maintain consistent levels of the medication in your body. Avoid consuming grapefruit or grapefruit juice while taking the tablet, as it can increase the risk of side effects. Do not stop taking Fenofibrate Nanocrystallized without consulting your healthcare provider. They may need to gradually reduce the dosage to avoid any potential rebound effects. 

Side Effects 

Common Side Effects 

• Abdominal pain 
• Allergic reactions such as rash or itching 
• Constipation 
• Diarrhea 
• Dizziness 
• Headache 
• Muscle pain 
• Nausea 

Serious Side Effects 

• Agitation 
• Bloating 
• Bloody urine 
• Chronic indigestion 
• Constipation 
• Dark urine 
• Decreased frequency or amount of urine 
• Difficulty in moving 
• Fast heartbeat 
• General tiredness and weakness 
• Increased blood pressure 
• Increased thirst 
• Indigestion 
• Joint pain or swelling 
• Light-colored stools 
• Loss of appetite 
• Lower back or side pain 
• Muscle cramps, spasms, stiffness, swelling, or weakness 
• Pains in the stomach, side, or abdomen, possibly radiating to the back 
• Pale skin 
• Swelling of the face, fingers, or lower legs 
• Troubled breathing 
• Troubled breathing with exertion 
• Unusual bleeding or bruising 
• Unusual tiredness or weakness 
• Upper right abdominal or stomach pain 
• Weight gain 
• Yellow eyes or skin 

Cautions 

• Known hypersensitivity: If you are allergic to fenofibrate or any ingredients contained in Tricor Nanocrystallized, you should not take the medication. 
• Severe renal impairment: The tablet is contraindicated in individuals with severe renal impairment, including those with end-stage renal disease and those receiving dialysis. Discuss your kidney function with your healthcare provider before starting fenofibrate therapy. 
• Active liver disease: Tricor Nanocrystallized is contraindicated in individuals with active liver disease. Inform your healthcare provider about any liver problems you may have. 
• Gallbladder disease: Fenofibrate Nanocrystallized has been associated with cholelithiasis (gallstones). If gallstones are detected upon gallbladder studies, it may be necessary to discontinue the medication. 
• Nursing mothers: Fenofibrate Nanocrystallized should not be used by nursing mothers. Consult with your healthcare provider if you are breastfeeding. 
• Myopathy, myositis, or rhabdomyolysis: Although rare, Fenofibrate Nanocrystallized has been reported to be associated with myopathy (muscle disease), myositis (muscle inflammation), or rhabdomyolysis (muscle breakdown). Monitoring may be required in some cases.